Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan W Partin

Showing results (301-310 of 349) with videos related to

Pageof 35
Sort By:
The Journal of Urology|October 9, 2003
Complexed prostate specific antigen improves specificity for prostate cancer detection: results of a prospective multicenter clinical trialAlan W Partin, Michael K Brawer, Georg Bartsch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 2011
PTEN protein loss by immunostaining: analytic validation and prognostic indicator for a high risk surgical cohort of prostate cancer patientsTamara L Lotan, Bora Gurel, Siobhan Sutcliffe, et al.
The Journal of Urology|May 31, 2016
SPINK1 Defines a Molecular Subtype of Prostate Cancer in Men with More Rapid Progression in an at Risk, Natural History Radical Prostatectomy CohortMichael H Johnson, Ashley E Ross, Mohammed Alshalalfa, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 12, 2011
Increased gene copy number of ERG on chromosome 21 but not TMPRSS2-ERG fusion predicts outcome in prostatic adenocarcinomasAntoun Toubaji, Roula Albadine, Alan K Meeker, et al.
Stem Cells Translational Medicine|March 30, 2019
In ReplyW Nathaniel Brennen, Michael T Schweizer, Hao Wang, et al.
Stem Cells Translational Medicine|February 9, 2019
A Phase I Study to Assess the Safety and Cancer-Homing Ability of Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells in Men with Localized Prostate CancerMichael T Schweizer, Hao Wang, Trinity J Bivalacqua, et al.
Plos One|January 6, 2016
Clinical Validation of the 2005 ISUP Gleason Grading System in a Cohort of Intermediate and High Risk Men Undergoing Radical ProstatectomySheila F Faraj, Stephania M Bezerra, Kasra Yousefi, et al.
The Prostate|May 13, 2009
Individual and cumulative effect of prostate cancer risk-associated variants on clinicopathologic variables in 5,895 prostate cancer patientsA Karim Kader, Jielin Sun, Sarah D Isaacs, et al.
JAMA|November 22, 2007
Obesity-related plasma hemodilution and PSA concentration among men with prostate cancerLionel L Bañez, Robert J Hamilton, Alan W Partin, et al.
The Prostate|May 21, 2008
Cumulative effect of five genetic variants on prostate cancer risk in multiple study populationsJielin Sun, Bao-Li Chang, Sarah D Isaacs, et al.
Pageof 35

Showing results (301-310 of 349) with videos related to

Sort By:
Pageof 35
The Journal of Urology|October 9, 2003
Complexed prostate specific antigen improves specificity for prostate cancer detection: results of a prospective multicenter clinical trialAlan W Partin, Michael K Brawer, Georg Bartsch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 2011
PTEN protein loss by immunostaining: analytic validation and prognostic indicator for a high risk surgical cohort of prostate cancer patientsTamara L Lotan, Bora Gurel, Siobhan Sutcliffe, et al.
The Journal of Urology|May 31, 2016
SPINK1 Defines a Molecular Subtype of Prostate Cancer in Men with More Rapid Progression in an at Risk, Natural History Radical Prostatectomy CohortMichael H Johnson, Ashley E Ross, Mohammed Alshalalfa, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 12, 2011
Increased gene copy number of ERG on chromosome 21 but not TMPRSS2-ERG fusion predicts outcome in prostatic adenocarcinomasAntoun Toubaji, Roula Albadine, Alan K Meeker, et al.
Stem Cells Translational Medicine|March 30, 2019
In ReplyW Nathaniel Brennen, Michael T Schweizer, Hao Wang, et al.
Stem Cells Translational Medicine|February 9, 2019
A Phase I Study to Assess the Safety and Cancer-Homing Ability of Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells in Men with Localized Prostate CancerMichael T Schweizer, Hao Wang, Trinity J Bivalacqua, et al.
Plos One|January 6, 2016
Clinical Validation of the 2005 ISUP Gleason Grading System in a Cohort of Intermediate and High Risk Men Undergoing Radical ProstatectomySheila F Faraj, Stephania M Bezerra, Kasra Yousefi, et al.
The Prostate|May 13, 2009
Individual and cumulative effect of prostate cancer risk-associated variants on clinicopathologic variables in 5,895 prostate cancer patientsA Karim Kader, Jielin Sun, Sarah D Isaacs, et al.
JAMA|November 22, 2007
Obesity-related plasma hemodilution and PSA concentration among men with prostate cancerLionel L Bañez, Robert J Hamilton, Alan W Partin, et al.
The Prostate|May 21, 2008
Cumulative effect of five genetic variants on prostate cancer risk in multiple study populationsJielin Sun, Bao-Li Chang, Sarah D Isaacs, et al.
Pageof 35